Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs

Scalable molecular dynamics with NAMD

Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20289 · Cited by 16,914 · see citing works

All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins

MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., Fischer, S., Gao, J., Guo, H., Ha, S., et al. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp973084f · Cited by 14,270 · see citing works

CHARMM General Force Field (CGenFF): A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields

Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P. E. M., Vorobyov, I., et al. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21367 · Cited by 6,986 · see citing works

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892 · see citing works

Extending the treatment of backbone energetics in protein force fields: Limitations of gas‐phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations

MacKerell, A. D., Feig, M., & Brooks, C. L. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20065 · Cited by 3,336 · see citing works

High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor

Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H., Kühn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,280 · see citing works

Well-Tempered Metadynamics: A Smoothly Converging and Tunable Free-Energy Method

Barducci, A., Bussi, G., & Parrinello, M. (2008) · Physical Review Letters · doi:10.1103/physrevlett.100.020603 · Cited by 3,184 · see citing works

Crystal structure of the β2 adrenergic receptor–Gs protein complex

Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009 · see citing works

The structure and function of G-protein-coupled receptors

Rosenbaum, D. M., Rasmussen, S. G. F., & Kobilka, B. K. (2009) · Nature · doi:10.1038/nature08144 · Cited by 2,534 · see citing works

PLUMED: A portable plugin for free-energy calculations with molecular dynamics

Bonomi, M., Branduardi, D., Bussi, G., Camilloni, C., Provasi, D., Raiteri, P., Donadio, D., Marinelli, F., Pietrucci, F., Broglia, R. A., et al. (2009) · Computer Physics Communications · doi:10.1016/j.cpc.2009.05.011 · Cited by 1,890 · see citing works

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.

Meltzer, H. Y., Matsubara, S., & Lee, J. C. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20710-8 · Cited by 1,352 · see citing works

The βγ subunits of GTP-binding proteins activate the muscarinic K+ channel in heart

Logothetis, D. E., Kurachi, Y., Galper, J., Neer, E. J., & Clapham, D. E. (1987) · Nature · doi:10.1038/325321a0 · Cited by 1,208 · see citing works

Heterotrimeric G protein activation by G-protein-coupled receptors

Oldham, W. M., & Hamm, H. E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2299 · Cited by 1,174 · see citing works

Crystal structure of opsin in its G-protein-interacting conformation

Scheerer, P., Park, J. H., Hildebrand, P. W., Kim, Y. J., Krauß, N., Choe, H.-W., Hofmann, K. P., & Ernst, O. P. (2008) · Nature · doi:10.1038/nature07330 · Cited by 1,059 · see citing works

The Retinal Conformation and its Environment in Rhodopsin in Light of a New 2.2 Å Crystal Structure

Okada, T., Sugihara, M., Bondar, A.-N., Elstner, M., Entel, P., & Buss, V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.07.044 · Cited by 1,049 · see citing works

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040 · see citing works

Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior

González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925 · see citing works

Identification of a serotonin/glutamate receptor complex implicated in psychosis

González-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., López-Giménez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., et al. (2008) · Nature · doi:10.1038/nature06612 · Cited by 803 · see citing works

Neurobiology of Schizophrenia

Ross, C. A., Margolis, R. L., Reading, S. A. J., Pletnikov, M. V., & Coyle, J. T. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.015 · Cited by 697 · see citing works

A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein

Whorton, M. R., Bokoch, M. P., Rasmussen, S. G. F., Huang, B., Zare, R. N., Kobilka, B. K., & Sunahara, R. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611448104 · Cited by 671 · see citing works

From A to B in free energy space.

Branduardi, D., Gervasio, F., & Parrinello, M. (2007) · Journal of Chemical Physics · doi:10.1063/1.2432340 · Cited by 596 · see citing works

Protein–Protein Docking with Backbone Flexibility

Wang, C., Bradley, P. H., & Baker, D. A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.07.050 · Cited by 417 · see citing works

Alterations in Conserved Kir Channel-PIP2 Interactions Underlie Channelopathies

Lopes, C. M. B., Zhang, H., Rohács, T., Jin, T., Yang, J., & Logothetis, D. E. (2002) · Neuron · doi:10.1016/s0896-6273(02)00725-0 · Cited by 395 · see citing works

Forced unfolding of fibronectin type 3 modules: an analysis by biased molecular dynamics simulations

Paci, E., & Karplus, M. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2670 · Cited by 344 · see citing works

Impairment of Hippocampal Mossy Fiber LTD in Mice Lacking mGluR2

Yokoi, M., Kobayashi, K., Manabe, T., Takahashi, T., Sakaguchi, I., Katsuura, G., Shigemoto, R., Ohishi, H., Nomura, S., Nakamura, K. D., et al. (1996) · Science · doi:10.1126/science.273.5275.645 · Cited by 340 · see citing works

Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation

Han, Y., Moreira, I. S., Urizar, E., Weinstein, H., & Javitch, J. A. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.199 · Cited by 339 · see citing works

G protein‐coupled receptor hetero‐dimerization: contribution to pharmacology and function

Milligan, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00169.x · Cited by 326 · see citing works

PCP: from pharmacology to modelling schizophrenia

MORRIS, B. J., Cochran, S. M., & Pratt, J. A. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.08.008 · Cited by 308 · see citing works

Comparative cytoarchitectonic atlas of the C57BL/6 and 129/Sv mouse brains

Hof, P. R. (2000) · Elsevier eBooks · Cited by 289 · see citing works

Detection of heteromerization of more than two proteins by sequential BRET-FRET

Carriba, P., Navarro, G., Ciruela, F., Ferré, S., Casadó, V., Agnati, L. F., Cortés, A., Mallol, J., Fuxé, K., Canela, E. I., et al. (2008) · Nature Methods · doi:10.1038/nmeth.1229 · Cited by 281 · see citing works

Phencyclidine animal models of schizophrenia: Approaches from abnormality of glutamatergic neurotransmission and neurodevelopment

Mouri, A., Noda, Y., Enomoto, T., & Nabeshima, T. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.019 · Cited by 267 · see citing works

Conformational cross-talk between α2A-adrenergic and μ-opioid receptors controls cell signaling

Vilardaga, J., Nikolaev, V. O., Lorenz, K., Ferrandon, S., Zhuang, Z., & Lohse, M. J. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.64 · Cited by 264 · see citing works

Efficacy at g-protein-coupled receptors

Kenakin, T. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd722 · Cited by 264 · see citing works

A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia

Kinon, B. J., Zhang, L., Millen, B. A., Osuntokun, O. O., Williams, J. E., Kollack-Walker, S., Jackson, K., Kryzhanovskaya, L., & Jarkova, N. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318218dcd5 · Cited by 256 · see citing works

Effective energy function for proteins in lipid membranes

Lazaridis, T. (2003) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10410 · Cited by 251 · see citing works

In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems

Meltzer, H. Y., & HUANG, M. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00909-6 · Cited by 248 · see citing works

Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists

Moreno, J. L., Holloway, T. D., Albizu, L., Sealfon, S. C., & González‐Maeso, J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.046 · Cited by 235 · see citing works

Molecular Interaction of Serotonin 5-HT2A Receptor Residues Phe339(6.51) and Phe340(6.52) with Superpotent N-Benzyl Phenethylamine Agonists

Braden, M. R., Parrish, J. C., Naylor, J. C., & Nichols, D. E. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028720 · Cited by 217 · see citing works

Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit

Ernst, O. P., Gramse, V., Kolbe, M., Hofmann, K. P., & Heck, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701967104 · Cited by 216 · see citing works

5-Hydroxytryptamine2A Receptor Inverse Agonists as Antipsychotics

Weiner, D. M., Burstein, E. S., Nash, N., Croston, G. E., Currier, E. A., Vanover, K. E., Harvey, S. C., Donohue, E., Hansen, H. C., Andersson, C. M., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29327-7 · Cited by 203 · see citing works

The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity

Woolley, M. L., Pemberton, D. J., Bate, S. T., Corti, C., & Jones, D. N. C. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0974-x · Cited by 189 · see citing works

Characteristic Interactions with Phosphatidylinositol 4,5-Bisphosphate Determine Regulation of Kir Channels by Diverse Modulators

Du, X., Zhang, H., Lopes, C. M. B., Mirshahi, T., Rohács, T., & Logothetis, D. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403413200 · Cited by 180 · see citing works

Psychedelics and schizophrenia

González‐Maeso, J., & Sealfon, S. C. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.005 · Cited by 168 · see citing works

The α1b-Adrenoceptor Exists as a Higher-Order Oligomer: Effective Oligomerization Is Required for Receptor Maturation, Surface Delivery, and Function

López‐Giménez, J. F., Canals, M., Pediani, J. D., & Milligan, G. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033035 · Cited by 165 · see citing works

Probing the G-protein Regulation of GIRK1 and GIRK4, the Two Subunits of the KACh Channel, Using Functional Homomeric Mutants

Vivaudou, M., Chan, K. W., Sui, J., Jan, L. Y., Reuveny, E., & Logothetis, D. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31553 · Cited by 164 · see citing works

The 'atypicality' of antipsychotics: a concept re-examined and re-defined

Gründer, G., Hippius, H., & Carlsson, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2806 · Cited by 154 · see citing works

Identification of Conserved Aromatic Residues Essential for Agonist Binding and Second Messenger Production at 5-Hydroxytryptamine2A Receptors

Roth, B. L., Shoham, M., Choudhary, M. S., & Khan, N. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.2.259 · Cited by 133 · see citing works

CODA-RET reveals functional selectivity as a result of GPCR heteromerization

Urizar, E., Yano, H., Kolster, R., Galès, C., Lambert, N. A., & Javitch, J. A. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.623 · Cited by 129 · see citing works

Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration

Rives, M., Vol, C., Fukazawa, Y., Tinel, N., Trinquet, E., Ayoub, M. A., Shigemoto, R., Pin, J., & Prézeau, L. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.177 · Cited by 127 · see citing works

Identification of a Potassium Channel Site That Interacts with G Protein βγ Subunits to Mediate Agonist-induced Signaling

He, C., Zhang, H., Mirshahi, T., & Logothetis, D. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12517 · Cited by 114 · see citing works

Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors

Aloyo, V. J., Berg, K. A., Spampinato, U., Clarke, W. P., & Harvey, J. A. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.010 · Cited by 109 · see citing works

Creation of a Constitutively Activated State of the 5-Hydroxytryptamine2A Receptor by Site-Directed Mutagenesis: Inverse Agonist Activity of Antipsychotic Drugs

Egan, C. T., Herrick‐Davis, K., & Teitler, M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37560-3 · Cited by 97 · see citing works

Identification of Critical Residues Controlling G Protein-gated Inwardly Rectifying K+ Channel Activity through Interactions with the βγ Subunits of G Proteins

He, C., Yan, X., Zhang, H., Mirshahi, T., Jin, T., Huang, A., & Logothetis, D. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104851200 · Cited by 96 · see citing works

An Epilepsy Mutation in the Sodium ChannelSCN1AThat Decreases Channel Excitability

Barela, A. J., Waddy, S. P., Lickfett, J., Hunter, J. E., Anido, A., Helmers, S. L., Goldin, A. L., & Escayg, A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2977-05.2006 · Cited by 94 · see citing works

Ligand-Induced Modulation of the Free-Energy Landscape of G Protein-Coupled Receptors Explored by Adaptive Biasing Techniques

Provasi, D., Artacho, M. C., Negri, A., Mobarec, J. C., & Filizola, M. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002193 · Cited by 94 · see citing works

Phosphatidylinositol-4,5-bisphosphate regulates epidermal growth factor receptor activation

Michailidis, I. E., Rusinova, R., Georgakopoulos, A., Chen, Y., Iyengar, R., Robakis, N. K. R. K., Logothetis, D. E., & Baki, L. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0904-3 · Cited by 94 · see citing works

Disrupting 5-HT2A Receptor/PDZ Protein Interactions Reduces Hyperalgesia and Enhances SSRI Efficacy in Neuropathic Pain

Pichon, X., Wattiez, A., Bécamel, C., Ehrlich, I., Bockaert, J., Eschalier, A., Marin, P., & Courteix, C. (2010) · Molecular Therapy · doi:10.1038/mt.2010.101 · Cited by 66 · see citing works

Group II metabotropic glutamate receptors and schizophrenia

Moreno, J. L., Sealfon, S. C., & González‐Maeso, J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0130-3 · Cited by 61 · see citing works

Habituation Deficits Induced by Metabotropic Glutamate Receptors 2/3 Receptor Blockade in Mice: Reversal by Antipsychotic Drugs

Bespalov, A., Jongen-Rêlo, A.-L., van Gaalen, M. M., Harich, S., Schoemaker, H., & Groß, G. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110684 · Cited by 49 · see citing works

Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding

Kanagarajadurai, K., Malini, M., Bhattacharya, A., Panicker, M. M., & Sowdhamini, R. (2009) · Molecular BioSystems · doi:10.1039/b906391a · Cited by 36 · see citing works

Combined administration of an mGlu2/3 receptor agonist and a 5-HT2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants

Uslaner, J. M., Smith, S. M., Huszar, S. L., Pachmerhiwala, R., Hinchliffe, R. M., Vardigan, J. D., & Hutson, P. H. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1644-y · Cited by 30 · see citing works

The use of MK-801, a novel sympathomimetic, in adults with attention deficit disorder, residual type.

Reimherr, F. W., Wood, D. R., & Wender, P. H. (1986) · PubMed · Cited by 20 · see citing works

Quantitative stoichiometry of G-proteins activated by μ-opioid receptors in postmortem human brain

González‐Maeso, J., Rodríguez‐Puertas, R., & Meana, J. J. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02242-2 · Cited by 16 · see citing works

Automation of the CHARMM General Force Field (CGenFF) I: bond perception and atom typing

Vanommeslaeghe, K., & MacKerell, A. D. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300363c · Cited by 2,028 · see citing works

Psychedelics

Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762 · see citing works

G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives

Ferré, S., Casadó, V., Devi, L. A., Filizola, M., Jockers, R., Lohse, M. J., Milligan, G., Pin, J., & Guitart, X. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008052 · Cited by 574 · see citing works

A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors

Jahchan, N. S., Dudley, J. T., Mazur, P. K., Flores, N. M., Yang, D., Palmerton, A., Zmoos, A., Vaka, D., Tran, K. Q. T., Zhou, M. J., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0183 · Cited by 358 · see citing works

Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways

López‐Giménez, J. F., & González‐Maeso, J. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_478 · Cited by 311 · see citing works

Control of lymphocyte egress from lymph nodes through β2-adrenergic receptors

Nakai, A., Hayano, Y., Furuta, F., Noda, M., & Suzuki, K. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20141132 · Cited by 290 · see citing works

HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

Kurita, M., Holloway, T. D., García‐Bea, A., Kozlenkov, A., Friedman, A. K., Moreno, J. L., Heshmati, M., Golden, S. A., Kennedy, P., Takahashi, N., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3181 · Cited by 278 · see citing works

Organization and functions of mGlu and GABAB receptor complexes

Pin, J., & Bettler, B. (2016) · Nature · doi:10.1038/nature20566 · Cited by 274 · see citing works

Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis

Pan, X., Kaminga, A. C., Wen, S. W., Wu, X., Acheampong, K., & Liu, A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00175 · Cited by 269 · see citing works

Distinct profiles of functional discrimination among G proteins determine the actions of G protein–coupled receptors

Masuho, I., Ostrovskaya, O. I., Kramer, G. M., Jones, C. D., Xie, K., & Martemyanov, K. A. (2015) · Science Signaling · doi:10.1126/scisignal.aab4068 · Cited by 259 · see citing works

G protein-coupled receptor heteromers

Gomes, I., Ayoub, M. A., Fujita, W., Jaeger, W. C., Pfleger, K. D. G., & Devi, L. A. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135952 · Cited by 262 · see citing works

Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders

Foster, D. J., & Conn, P. J. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.016 · Cited by 227 · see citing works

Psychedelic-inspired drug discovery using an engineered biosensor

Dong, C., Ly, C., Dunlap, L. E., Vargas, M. V., Sun, J., Hwang, I.-W., Azinfar, A., Oh, W. C., Wetsel, W. C., Olson, D. E., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.043 · Cited by 213 · see citing works

Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors

Viñals, X., Moreno, E., Lanfumey, L., Cordomí, A., Pastor, A., de la Torre, R., Gasperini, P., Navarro, G., Howell, L. A., Pardo, L., et al. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002194 · Cited by 207 · see citing works

Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences

Aringhieri, S., Carli, M., Kolachalam, S., Verdesca, V., Cinì, E., Rossi, M., McCormick, P., Corsini, G., Maggio, R., & Scarselli, M. (2018) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2018.06.012 · Cited by 182 · see citing works

Major ligand-induced rearrangement of the heptahelical domain interface in a GPCR dimer

Li, X., Rovira, X., Scholler, P., Zhao, H., Liu, J., Pin, J., & Rondard, P. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1711 · Cited by 189 · see citing works

Molecular Dynamics Simulations: Concept, Methods, and Applications

Badar, M. S., Shamsi, S., Ahmed, J., & Alam, M. A. (2022) · Integrated science · doi:10.1007/978-3-030-94651-7_7 · Cited by 172 · see citing works

Cytokine Response Is Determined by Duration of Receptor and Signal Transducers and Activators of Transcription 3 (STAT3) Activation

Braun, D. A., Fribourg, M., & Sealfon, S. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.386573 · Cited by 168 · see citing works

Inhibition of the TRPC5 ion channel protects the kidney filter

Schaldecker, T., Kim, S., Tarabanis, C., Tian, D., Hakroush, S., Castonguay, P., Ahn, W., Wallentin, H., Heid, H., Hopkins, C. R., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci71165 · Cited by 167 · see citing works

G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders

Wong, T., Li, G., Li, S., Gao, W., Chen, G., Gan, S., Zhang, M., Li, H., Wu, S., & Du, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01427-2 · Cited by 168 · see citing works

Animal Models of Serotonergic Psychedelics

Hanks, J. B., & González-Maeso, J. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn300138m · Cited by 156 · see citing works

Promiscuous Dimerization of the Growth Hormone Secretagogue Receptor (GHS-R1a) Attenuates Ghrelin-mediated Signaling

Schellekens, H., van Oeffelen, W. E. P. A., Dinan, T. G., & Cryan, J. F. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382473 · Cited by 153 · see citing works

Major channels involved in neuropsychiatric disorders and therapeutic perspectives

Imbrici, P., Camerino, D. C., & Tricarico, D. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00076 · Cited by 148 · see citing works

Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential

Seyedabadi, M., Ghahremani, M. H., & Albert, P. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.006 · Cited by 148 · see citing works

Identification of Three Residues Essential for 5-Hydroxytryptamine 2A-Metabotropic Glutamate 2 (5-HT2A·mGlu2) Receptor Heteromerization and Its Psychoactive Behavioral Function

Moreno, J. L., Muguruza, C., Umali, A., Mortillo, S., Holloway, T. D., Pilar-Cuéllar, F., Mocci, G., Seto, J., Callado, L. F., Neve, R. L., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.413161 · Cited by 140 · see citing works

Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety

Asan, E., Steinke, M. R., & Lesch, K. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1081-1 · Cited by 137 · see citing works

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences

Carbonaro, T. M., Johnson, M. W., Hurwitz, E., & Griffiths, R. R. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4769-4 · Cited by 133 · see citing works

Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?

Guiard, B. P., & Giovanni, G. D. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00046 · Cited by 132 · see citing works

Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity

Olson, D. E. (2022) · Biochemistry · doi:10.1021/acs.biochem.1c00812 · Cited by 135 · see citing works

Convergence of Melatonin and Serotonin (5-HT) Signaling at MT2/5-HT2C Receptor Heteromers

Kamal, M. T., Gbahou, F., Guillaume, J., Daulat, A. M., Benleulmi‐Chaachoua, A., Luka, M., Chen, P. B., Anaraki, D. K., Baroncini, M., la Cour, C. M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559542 · Cited by 128 · see citing works

Targeting metabotropic glutamate receptors for novel treatments of schizophrenia

Maksymetz, J., Moran, S. P., & Conn, P. J. (2017) · Molecular Brain · doi:10.1186/s13041-017-0293-z · Cited by 128 · see citing works

Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase

Navarro, G., Cordomí, A., Casadó-Anguera, V., Moreno, E., Cai, N.-S., Cortés, A., Canela, E. I., DESSAUER, C. W., Casadó, V., Pardo, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03522-3 · Cited by 120 · see citing works

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology

Gregorio, D. D., Comai, S., Posa, L., & Gobbi, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111953 · Cited by 124 · see citing works

Prenatal Stress Induces Schizophrenia-Like Alterations of Serotonin 2A and Metabotropic Glutamate 2 Receptors in the Adult Offspring: Role of Maternal Immune System

Holloway, T. D., Moreno, J. L., Umali, A., Rayannavar, V., Hodes, G. E., Russo, S. J., & González‐Maeso, J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2331-12.2013 · Cited by 121 · see citing works

Allosteric signaling through an mGlu2 and 5-HT2Aheteromeric receptor complex and its potential contribution to schizophrenia

Moreno, J. L., Miranda-Azpiazu, P., García‐Bea, A., Younkin, J., Cui, M., Kozlenkov, A., Ben-Ezra, A., Voloudakis, G., Fakira, A. K., Baki, L., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aab0467 · Cited by 114 · see citing works

Enhanced sampling techniques in biomolecular simulations

Spiwok, V., Sucur, Z., & Hosek, P. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.11.011 · Cited by 110 · see citing works

Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype–targeted drugs

Meltzer, H. Y., & Roth, B. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70678 · Cited by 109 · see citing works

Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs

Navarro, G., Cordomí, A., Zelman-Femiak, M., Brugarolas, M., Moreno, E., Aguinaga, D., Pérez‐Benito, L., Cortés, A., Casadó, V., Mallol, J., et al. (2016) · BMC Biology · doi:10.1186/s12915-016-0247-4 · Cited by 108 · see citing works

A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics

Savalia, N. K., Shao, L.-X., & Kwan, A. C. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2020.11.008 · Cited by 104 · see citing works

Structural and Biophysical Mechanisms of Class C G Protein-Coupled Receptor Function

Ellaithy, A., González‐Maeso, J., Logothetis, D. E., & Levitz, J. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.07.008 · Cited by 102 · see citing works

Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes

Blough, B. E., Landavazo, A., Decker, A. M., Partilla, J. S., Baumann, M. H., & Rothman, R. B. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3557-7 · Cited by 101 · see citing works

Reactive oxygen species are second messengers of neurokinin signaling in peripheral sensory neurons

Linley, J. E., Ooi, L., Pettinger, L., Kirton, H. M., Boyle, J. P., Peers, C., & Gamper, N. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201544109 · Cited by 100 · see citing works

Serotonergic Mechanisms as Targets for Existing and Novel Antipsychotics

Meltzer, H. Y. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_4 · Cited by 96 · see citing works

The Prevalence, Maintenance, and Relevance of G Protein–Coupled Receptor Oligomerization

Milligan, G. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.084780 · Cited by 98 · see citing works

Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: Comparison with reference dose risperidone, 6mg/day

Meltzer, H. Y., Elkis, H., Vanover, K. E., Weiner, D. M., van Kammen, D. P., Peters, P., & Hacksell, U. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.07.029 · Cited by 95 · see citing works

Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades

Delille, H. K., Becker, J. M., Burkhardt, S., Bleher, B., Terstappen, G. C., Schmidt, M. U., Meyer, A. H., Unger, L., Marek, G. J., & Mezler, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.010 · Cited by 93 · see citing works

Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery

Conflitti, P., Lyman, E. R., Sansom, M. S. P., Hildebrand, P. W., Gutiérrez‐de‐Terán, H., Carloni, P., Ansell, T. B., Yuan, S., Barth, P., Robinson, A. S., et al. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01083-3 · Cited by 97 · see citing works

High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens

Reissig, C. J., Carter, L. P., Johnson, M. W., Mintzer, M. Z., Klinedinst, M. A., & Griffiths, R. R. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2680-6 · Cited by 90 · see citing works

Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins

de Bartolomeis, A., Buonaguro, E. F., & Iasevoli, F. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2921-8 · Cited by 89 · see citing works

Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism

Meinhardt, M. W., Pfarr, S., Fouquet, G., Rohleder, C., Meinhardt, M. L., Barroso-Flores, J., Hoffmann, R., Jeanblanc, J., Paul, E., Wagner, K., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh2399 · Cited by 89 · see citing works

G‐protein coupled receptors and ligands that organize humoral immune responses

Lu, E., & Cyster, J. G. (2019) · Immunological Reviews · doi:10.1111/imr.12743 · Cited by 84 · see citing works

Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia

de Bartolomeis, A., Vellucci, L., Barone, A., Manchia, M., Luca, V. D., Iasevoli, F., & Correll, C. U. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108236 · Cited by 88 · see citing works

Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects

Muguruza, C., Moreno, J. L., Umali, A., Callado, L. F., Meana, J. J., & González‐Maeso, J. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.10.006 · Cited by 86 · see citing works

Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets

Mallipeddi, S., Janero, D. R., Zvonok, N., & Makriyannis, A. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.014 · Cited by 84 · see citing works

A Functional Selectivity Mechanism at the Serotonin-2A GPCR Involves Ligand-Dependent Conformations of Intracellular Loop 2

Perez‐Aguilar, J. M., Shan, J., Levine, M. V., Khelashvili, G., & Weinstein, H. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508394x · Cited by 81 · see citing works

BRET and Time-resolved FRET strategy to study GPCR oligomerization: from cell lines toward native tissues

Cottet, M., Faklaris, O., Maurel, D., Scholler, P., Doumazane, E., Trinquet, E., Pin, J., & Durroux, T. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00092 · Cited by 81 · see citing works

Revealing G‐protein‐coupled receptor oligomerization at the single‐molecule level through a nanoscopic lens: methods, dynamics and biological function

Scarselli, M., Annibale, P., McCormick, P. J., Kolachalam, S., Aringhieri, S., Rađenović, A., Corsini, G. U., & Maggio, R. (2015) · FEBS Journal · doi:10.1111/febs.13577 · Cited by 79 · see citing works

Nongenetic engineering strategies for regulating receptor oligomerization in living cells

Li, J., Wang, L., Tian, J., Zhou, Z.-L., Li, J., & Yang, H. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00473d · Cited by 76 · see citing works

G protein-coupled receptor heteromers are key players in substance use disorder

Derouiche, L., & Massotte, D. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.026 · Cited by 76 · see citing works

Allosteric control of an asymmetric transduction in a G protein-coupled receptor heterodimer

Liu, J., Zhang, Z., Moreno‐Delgado, D., Dalton, J. A. R., Rovira, X., Trapero, A., Goudet, C., Llebaria, A., Giraldo, J., Yuan, Q., et al. (2017) · eLife · doi:10.7554/elife.26985 · Cited by 73 · see citing works

The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs

Riga, M. S., Sòria, G., Tudela, R., Artigas, F., & Celada, P. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000261 · Cited by 72 · see citing works

Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?

Li, M.-L., Hu, X., Li, F., & Gao, W. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.02.012 · Cited by 71 · see citing works

The impact of metabotropic glutamate receptors into active neurodegenerative processes: A “dark side” in the development of new symptomatic treatments for neurologic and psychiatric disorders

Bruno, V., Caraci, F., Copani, A., Matrisciano, F., Nicoletti, F., & Battaglia, G. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.044 · Cited by 71 · see citing works

Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment

Muguruza, C., Miranda-Azpiazu, P., Dı́ez-Alarcia, R., Morentín, B., González‐Maeso, J., Callado, L. F., & Meana, J. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.08.009 · Cited by 69 · see citing works

Serotonergic hallucinogens as translational models relevant to schizophrenia

Halberstadt, A. L., & Geyer, M. A. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000722 · Cited by 69 · see citing works

The two faces of the pharmacological interaction of mGlu2 and 5-HT2A – Relevance of receptor heterocomplexes and interaction through functional brain pathways

Delille, H. K., Mezler, M., & Marek, G. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.005 · Cited by 68 · see citing works

New therapeutic opportunities for 5-HT2 receptor ligands

Maroteaux, L., Ayme‐Dietrich, E., Aubertin-Kirch, G., Banas, S. M., Quentin, E., Lawson, R., & Monassier, L. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.10.008 · Cited by 68 · see citing works

Clozapine Acts as an Agonist at Serotonin 2A Receptors to Counter MK-801-Induced Behaviors through a βArrestin2-Independent Activation of Akt

Schmid, C. L., Streicher, J. M., Meltzer, H. Y., & Bohn, L. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.38 · Cited by 67 · see citing works

Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers

Moutkine, I., Quentin, E., Guiard, B. P., Maroteaux, L., & Doly, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.779041 · Cited by 67 · see citing works

CrossTalk proposal: Weighing the evidence for Class A GPCR dimers, the evidence favours dimers

Bouvier, M., & Hébert, T. E. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.272252 · Cited by 65 · see citing works

Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment

Ellaithy, A., Younkin, J., González‐Maeso, J., & Logothetis, D. E. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.06.002 · Cited by 64 · see citing works

Psychedelic‐inspired approaches for treating neurodegenerative disorders

Saeger, H. N., & Olson, D. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15544 · Cited by 65 · see citing works

Heterodimerization Between the Lutropin and Follitropin Receptors is Associated With an Attenuation of Hormone-Dependent Signaling

Feng, X., Zhang, M., Guan, R., & Segaloff, D. L. (2013) · Endocrinology · doi:10.1210/en.2013-1407 · Cited by 64 · see citing works

International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors

Gregory, K. J., & Goudet, C. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.019133 · Cited by 64 · see citing works

Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges

Lee, J., Nam, D., & Lee, J. (2016) · Oncology Letters · doi:10.3892/ol.2016.4074 · Cited by 63 · see citing works

G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)

Ferré, S., Ciruela, F., DESSAUER, C. W., González‐Maeso, J., Hébert, T. E., Jockers, R., Logothetis, D. E., & Pardo, L. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107977 · Cited by 58 · see citing works

GPCR heteromers: An overview of their classification, function and physiological relevance

Dale, N. C., Johnstone, E. K. M., & Pfleger, K. D. G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.931573 · Cited by 61 · see citing works

Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs

Muguruza, C., Meana, J. J., & Callado, L. F. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00130 · Cited by 61 · see citing works

Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons

Marek, G. J. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_480 · Cited by 63 · see citing works

Contribution of heteromerization to G protein-coupled receptor function

Gaitonde, S. A., & González‐Maeso, J. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.10.006 · Cited by 60 · see citing works

Fully automated head-twitch detection system for the study of 5-HT2A receptor pharmacology in vivo

Revenga, M. D. L. F., Shin, J. M., Vohra, H., Hideshima, K. S., Schneck, M. B., Poklis, J. L., & González‐Maeso, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-49913-4 · Cited by 59 · see citing works

The roles played by highly truncated splice variants of G protein-coupled receptors

Wise, H. M. (2012) · Journal of Molecular Signaling · doi:10.1186/1750-2187-7-13 · Cited by 57 · see citing works

Minireview: Role of Intracellular Scaffolding Proteins in the Regulation of Endocrine G Protein-Coupled Receptor Signaling

Walther, C., & Ferguson, S. S. G. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1091 · Cited by 57 · see citing works

Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins

García‐Bea, A., Miranda-Azpiazu, P., Muguruza, C., Marmolejo-Martínez-Artesero, S., Dı́ez-Alarcia, R., Gabilondo, A. M., Callado, L. F., Morentín, B., González‐Maeso, J., & Meana, J. J. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.10.013 · Cited by 56 · see citing works

Serotonergic Hallucinogens and Emerging Targets for Addiction Pharmacotherapies

Ross, S. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.04.002 · Cited by 54 · see citing works

Psychiatric Drugs Bind to Classical Targets Within Early Exocytotic Pathways: Therapeutic Effects

Lester, H. A., Miwa, J. M., & Srinivasan, R. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.020 · Cited by 53 · see citing works

Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity

Revenga, M. D. L. F., Ibi, D., Cuddy, T., Toneatti, R., Kurita, M., Ijaz, M. K., Miles, M. F., Wolstenholme, J. T., & González‐Maeso, J. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0143-4 · Cited by 53 · see citing works

Arrestin recruitment and signaling by G protein-coupled receptor heteromers

Mores, K. L., Cassell, R. J., & van Rijn, R. M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.010 · Cited by 49 · see citing works

Serotonin and Glutamate Interactions in Preclinical Schizophrenia Models

Shah, U. H., & González-Maeso, J. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00044 · Cited by 44 · see citing works

Preclinical evaluation of the antipsychotic potential of the mGlu2‐positive allosteric modulator JNJ‐40411813

Lavreysen, H., Langlois, X., Donck, L. V., Cid, J. M., Pype, S., Lütjens, R., & Megens, A. A. H. P. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.97 · Cited by 47 · see citing works

Oligomerization of a G protein-coupled receptor in neurons controlled by its structural dynamics

Møller, T. C., Hottin, J., Clerté, C., Zwier, J. M., Durroux, T., Rondard, P., Prézeau, L., Royer, C. A., Pin, J., Margeat, E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28682-6 · Cited by 47 · see citing works

Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT 2A receptor agonism

Aringhieri, S., Kolachalam, S., Gerace, C., Carli, M., Verdesca, V., Brunacci, M. G., Rossi, C., Ippolito, C., Solini, A., Corsini, G. U., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.02.005 · Cited by 46 · see citing works

Dimers of serotonin receptors: Impact on ligand affinity and signaling

Maroteaux, L., Béchade, C., & Roumier, A. (2019) · Biochimie · doi:10.1016/j.biochi.2019.01.009 · Cited by 44 · see citing works

From Atomic Structures to Neuronal Functions of G Protein–Coupled Receptors

Palczewski, K., & Orban, T. (2013) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062012-170313 · Cited by 44 · see citing works

Chronic treatment with LY341495 decreases 5-HT2A receptor binding and hallucinogenic effects of LSD in mice

Moreno, J. L., Holloway, T. D., Rayannavar, V., Sealfon, S. C., & González‐Maeso, J. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2012.12.053 · Cited by 44 · see citing works

Dopamine D2 heteroreceptor complexes and their receptor–receptor interactions in ventral striatum

Fuxé, K., Borroto‐Escuela, D. O., Tarakanov, A. O., Romero‐Fernandez, W., Ferraro, L., Tanganelli, S., Pérez‐Alea, M., Palma, M. D., & Agnati, L. F. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63425-2.00005-2 · Cited by 43 · see citing works

Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia

Nicoletti, F., Orlando, R., Menna, L. D., Cannella, M., Notartomaso, S., Mascio, G., Iacovelli, L., Matrisciano, F., Fazio, F., Caraci, F., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00049 · Cited by 45 · see citing works

Interclass GPCR heteromerization affects localization and trafficking

Toneatti, R., Shin, J. M., Shah, U. H., Mayer, C. R., Saunders, J. M., Fribourg, M., Arsenovic, P. T., Janssen, W. G. M., Sealfon, S. C., López‐Giménez, J. F., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aaw3122 · Cited by 43 · see citing works

Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT2A and dopamine D2 receptors in rat prefrontal cortex

Franklin, J. M., & Carrasco, G. A. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112450786 · Cited by 42 · see citing works

Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor

Gaitonde, S. A., Avet, C., Revenga, M. D. L. F., Blondel-Tepaz, É., Shahraki, A., Pastor, A. M., Talagayev, V., Robledo, P., Kolb, P., Selent, J., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02531-7 · Cited by 42 · see citing works

Unifying antipsychotic drugs

Feliciano, P. (2011) · Nature Genetics · doi:10.1038/ng.1063

EPA-1211 – Role of 5-HT2a and mglu2 as a gpcr heterocomplex in antipsychotic action

González‐Maeso, J. (2014) · European Psychiatry · doi:10.1016/s0924-9338(14)78457-3

Role of interaction of mGlu2 and 5-HT2A receptors in antipsychotic effects

Ibi, D. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173474 · Cited by 21 · see citing works

Cross-Signaling between the Metabotropic Glutamate 2 Receptor and the Serotonin (5-Ht) 2A Receptor in Hek-293 Cells

Baki, L., Younkin, J., Eltit, J. M., Fribourg, M., Park, G., Vysotskaya, Z. V., & Logothetis, D. E. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2013.11.642

Functional Signaling Changes Resulting from GPCR Heteromerization: Relevance to Psychosis

Younkin, J., & Logothetis, D. E. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2012.11.669